Neuroprotexeon
Get Full AccessDescription
- NeuroproteXeon is a late clinical-stage pharmaceutical company developing the proprietary use of xenon gas, delivered via a patented inhalation device, to protect against brain cell death following acute neurologic injury. NP is currently preparing for a Phase III Clinical Trial in Out of Hospital Cardiac Arrest (OHCA).
-
Headquarters:50 Cobham Drive , Orchard Park, New York, United States
More -
Phone Number: +1 716-332-7200
-
Website: https://www.neuroprotexeon.com
-
Employees:10
-
Revenue:$1 - 10M
-
Legal Name:Neuroprotexeon
-
Neuroprotexeon's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Neuroprotexeon
-
Where are Neuroprotexeon's Headquarters?
Neuroprotexeon's Headquarters are in 50 Cobham Drive ,Orchard Park,New York,United States
-
What is Neuroprotexeon's phone number?
Neuroprotexeon's phone number is +1 716-332-7200
-
What is Neuroprotexeon's official website?
Neuroprotexeon's official website is https://www.neuroprotexeon.com
-
What is Neuroprotexeon's Revenue?
Neuroprotexeon's revenue is $1 - 10M
-
What is Neuroprotexeon's NAICS code?
Neuroprotexeon's NAICS code is 541713
-
How many employees are working in Neuroprotexeon
Neuroprotexeon has 10 employees
-
What is Neuroprotexeon's Industry?
Neuroprotexeon is in the industry of Pharmaceuticals
-
Who is Neuroprotexeon's CEO?
Neuroprotexeon's CEO is Bill Burns